These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8625335)

  • 41. 5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration.
    Buter J; Sinnige HA; Sleijfer DT; de Vries EG; Willemse PH; van der Graaf WT; Verschueren RC; Mulder NH
    Cancer; 1995 Mar; 75(5):1072-6. PubMed ID: 7850703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.
    Cascinu S; Fedeli A; Fedeli SL; Catalano G
    Ann Oncol; 1992 Jun; 3(6):489-91. PubMed ID: 1498068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patients.
    Brunetti I; Falcone A; Bertuccelli M; Cianci C; Ricci S; Conte PF
    Am J Clin Oncol; 1994 Jun; 17(3):210-4. PubMed ID: 8192103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I trial of fluorouracil, leucovorin, and recombinant interferon alpha-2b in patients with advanced malignancy.
    Taylor CW; Modiano MR; Woodson ME; Marcus SG; Alberts DS; Hersh EM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):185-90. PubMed ID: 1557645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of [6S]-N5-formyltetrahydrofolic acid on the bioavailability of 5-fluorouracil combined with interferon-alpha-2b.
    Czejka MJ; Schüller J; Fogl U
    Arch Pharm (Weinheim); 1992 Jun; 325(6):373-4. PubMed ID: 1444758
    [No Abstract]   [Full Text] [Related]  

  • 46. Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.
    Temeck BK; Liebmann JE; Theodossiou C; Steinberg SM; Cook JA; Metz DC; Shawker TH; Allegra CJ; Russo A; Pass HI
    Cancer; 1996 Jun; 77(12):2432-9. PubMed ID: 8640689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer].
    Tsuji Y; Nakamura T; Katagiri E; Kawanishi J; Handa H; Honjo K; Uehara S; Izumiyama S; Hirayama A; Sagawa T
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():419-25. PubMed ID: 7802444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Outpatient chemotherapy with infusional 5-fluorouracil in advanced gastrointestinal cancer].
    Tsuji Y; Miyajima N; Kuroiwa G; Kato M; Nobuoka A; Ohi M; Honjo K
    Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():346-50. PubMed ID: 10630245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413).
    Macdonald JS; Jacobson JL; Modiano M; Moore DF; Gandara DR; Schroder LE; Chapman RA
    Invest New Drugs; 2000 Aug; 18(3):269-73. PubMed ID: 10958597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma.
    Cascinu S; Del Ferro E; Ligi M; Catalano G
    Anticancer Drugs; 1996 Jul; 7(5):520-4. PubMed ID: 8862717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
    Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies.
    Valone FH; Gandara DR; Luce JA; Wall S; Perez EA; Braham N; George M; Letvak L
    Cancer Chemother Pharmacol; 1993; 32(3):215-20. PubMed ID: 8500227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced cytotoxicity of 5-fluorouracil combined with [6RS]leucovorin and recombinant human interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Adkins DA; Houghton PJ
    Adv Exp Med Biol; 1993; 339():133-42; discussion 165-7. PubMed ID: 8178712
    [No Abstract]   [Full Text] [Related]  

  • 54. Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumors.
    Adenis A; Leriche N; Pion JM; Vanlemmens L; Bonneterre J
    Anticancer Res; 1996; 16(4A):2063-7. PubMed ID: 8712743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is lanreotide and/or interferon alfa an adequate therapy for neuroendocrine tumors?
    Völter V; Peschel C
    J Clin Oncol; 2004 Feb; 22(3):573; author reply 574-5. PubMed ID: 14752089
    [No Abstract]   [Full Text] [Related]  

  • 56. Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.
    Fleming GF; O'Brien SM; Hoffman PC; Vokes EE; Vogelzang NJ; Schilsky RL; Waggoner SE; Ratain MJ
    Cancer Chemother Pharmacol; 1997; 39(3):227-32. PubMed ID: 8996525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxyurea may increase the activity of fluorouracil plus folinic acid in advanced gastrointestinal cancer: phase II study.
    Di Costanzo F; el-Taani H; Parriani D; Tagliaventi M; Bartolucci R; Valenti L; Manzione L; Madejewicz S
    Cancer Invest; 1996; 14(3):234-8. PubMed ID: 8630685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
    Wolmark N; Bryant J; Smith R; Grem J; Allegra C; Hyams D; Atkins J; Dimitrov N; Oishi R; Prager D; Fehrenbacher L; Romond E; Colangelo L; Fisher B
    J Natl Cancer Inst; 1998 Dec; 90(23):1810-6. PubMed ID: 9839521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
    Seymour MT; Patel N; Johnston A; Joel SP; Slevin ML
    Br J Cancer; 1994 Oct; 70(4):724-8. PubMed ID: 7917928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.